The CBTN dataset is thorough and comprehensive, as well as rich in clinical metadata. This will allow us to integrate genomic and expression information in order to help justify the use of PDGFRA targeted therapy in H3K27M high grade gliomas.
Get the Latest
news, articles, and resources sent to your inbox.
